Death, danger & immunity: Fundamental mechanisms linking pathogenic or iatrogenic cell death events to immune responses

Guido Kroemer

doi:10.1111/imr.12604

Death, danger & immunity: Fundamental mechanisms linking pathogenic or iatrogenic cell death events to immune responses

Guido Kroemer

Résultats de recherche: Contribution à un journal › Editorial

8 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	5-7
Nombre de pages	3
journal	Immunological Reviews
Volume	280
Numéro de publication	1
Les DOIs	https://doi.org/10.1111/imr.12604
état	Publié - 1 nov. 2017

Accès au document

10.1111/imr.12604

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{ba542d7ee79843deb67f5e0a31d22ac4,

title = "Death, danger & immunity: Fundamental mechanisms linking pathogenic or iatrogenic cell death events to immune responses",

author = "Guido Kroemer",

note = "Funding Information: Agence Nationale de la Recherche; Institut National Du Cancer; Fondation pour la Recherche M{\'e}dicale; ACG Institute for Clinical Research and Education; European Research Council; Ligue contre le Cancer Comit{\'e} de Charente-Maritime ({\'e}quipe labelis{\'e}e); Agence National de la Recherche (ANR) – Projets blancs; Association pour la recherche sur le cancer (ARC); Canc{\'e}rop{\^o}le Ile-de-France; Institut National du Cancer (INCa); Inserm (HTE); Institut Universitaire de France; Fondation pour la Recherche M{\'e}dicale (FRM); the European Commission (ArtForce); the European Research Council (ERC); Fondation Carrefour; the LeDucq Foundation; the LabEx Immuno-Oncology; the RHU Torino Lumi{\`e}re: the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); the SIRIC Cancer Research and Personalized Medicine (CARPEM); the Paris Alliance of Cancer Research Institutes (PACRI) Funding Information: This work was supported by the Ligue contre le Cancer Comit{\'e} de Charente-Maritime ({\'e}quipe labelis{\'e}e); Agence National de la Recherche (ANR) – Projets blancs; ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases; Association pour la recherche sur le cancer (ARC); Canc{\'e}rop{\^o}le Ile-de-France; Institut National du Cancer (INCa); Inserm (HTE); Institut Universitaire de France; Fondation pour la Recherche M{\'e}dicale (FRM); the European Commission (ArtForce); the European Research Council (ERC); Fondation Carrefour; the LeDucq Foundation; the LabEx Immuno-Oncology; the RHU Torino Lumi{\`e}re: the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); the SIRIC Cancer Research and Personalized Medicine (CARPEM); and the Paris Alliance of Cancer Research Institutes (PACRI).",

year = "2017",

month = nov,

day = "1",

doi = "10.1111/imr.12604",

language = "English",

volume = "280",

pages = "5--7",

journal = "Immunological Reviews",

issn = "0105-2896",

number = "1",

}

TY - JOUR

T1 - Death, danger & immunity

T2 - Fundamental mechanisms linking pathogenic or iatrogenic cell death events to immune responses

AU - Kroemer, Guido

N1 - Funding Information: Agence Nationale de la Recherche; Institut National Du Cancer; Fondation pour la Recherche Médicale; ACG Institute for Clinical Research and Education; European Research Council; Ligue contre le Cancer Comité de Charente-Maritime (équipe labelisée); Agence National de la Recherche (ANR) – Projets blancs; Association pour la recherche sur le cancer (ARC); Cancéropôle Ile-de-France; Institut National du Cancer (INCa); Inserm (HTE); Institut Universitaire de France; Fondation pour la Recherche Médicale (FRM); the European Commission (ArtForce); the European Research Council (ERC); Fondation Carrefour; the LeDucq Foundation; the LabEx Immuno-Oncology; the RHU Torino Lumière: the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); the SIRIC Cancer Research and Personalized Medicine (CARPEM); the Paris Alliance of Cancer Research Institutes (PACRI) Funding Information: This work was supported by the Ligue contre le Cancer Comité de Charente-Maritime (équipe labelisée); Agence National de la Recherche (ANR) – Projets blancs; ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases; Association pour la recherche sur le cancer (ARC); Cancéropôle Ile-de-France; Institut National du Cancer (INCa); Inserm (HTE); Institut Universitaire de France; Fondation pour la Recherche Médicale (FRM); the European Commission (ArtForce); the European Research Council (ERC); Fondation Carrefour; the LeDucq Foundation; the LabEx Immuno-Oncology; the RHU Torino Lumière: the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); the SIRIC Cancer Research and Personalized Medicine (CARPEM); and the Paris Alliance of Cancer Research Institutes (PACRI).

PY - 2017/11/1

Y1 - 2017/11/1

UR - http://www.scopus.com/inward/record.url?scp=85031127810&partnerID=8YFLogxK

U2 - 10.1111/imr.12604

DO - 10.1111/imr.12604

M3 - Editorial

C2 - 29027215

AN - SCOPUS:85031127810

SN - 0105-2896

VL - 280

SP - 5

EP - 7

JO - Immunological Reviews

JF - Immunological Reviews

IS - 1

ER -